Utilization of the TAD Device for Dispensing Pain Medications in Hospice Patients

Medication Adherence Clinical Trial

Official title: Utilization of the TAD Device for Dispensing Pain Medications in Hospice Patients

Status Completed

Clinical Trial Summary

A novel device, TAD, has been developed to aid adherence to prescribed regimens and may have a roll in hospice pain management. This study aims to assess medication adherence relating to missed doses or improperly timed doses with and without the aid of a mobile device as a primary endpoint. Secondary endpoints will be patient, nursing, and provider satisfaction.

Clinical Trial Description

This study is a randomized crossover study in which patients will be randomized to start with or without a mobile device assisting the patient or caregiver in using the device. The investigators aim to enroll 20 patients across 3 sites. Each patient is expected to participate in the study for 12 weeks. After the first 2 weeks of participation, the patient will either begin using the mobile device to assist or will stop using the mobile device for the next 2 weeks. after the initial 4 weeks, the patient will choose to continue with or without using the mobile device. ;

Related Conditions & MeSH terms

• Medication Adherence
• Satisfaction, Personal

• NCT number: NCT03940534
• Study type: Interventional
• Source: Intent Solutions, Inc.
• Status: Completed
• Phase: N/A
• Start date: March 9, 2018
• Completion date: February 26, 2019